makes its measurement in blood useful to ascertain that dosage is adequate.
The long half-lives are an advantage once therapeutic doses are achieved, but the time required to achieve steady state may be unduly long if there is no monitoring.
In This may be ascribed to trapping of prealbumin in the clot or to the relative insolubility of fibrinogen under these assay conditions. Figure 2 shows the age-specific mean (±2 SD) concentrations of prealbumin for our 76 subjects. The number of children in each age group are: 0-5.9 months, 13; 6-11.9 months, 24; 12-17.9 months, 20; 18-23.9 months, eight; and 
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